Precise screening to help the prevention and control of the disease, Wuhan has steadily promoted the "323" campaign

The Yangtze River Daily Da Wuhan Client July 19 (Reporter Wang Kaining) On July 18, the "2022 Healthy China Development Conference" was held in Beijing. Liu Qingxiang, a second -level inspector of the Wuhan Health and Health Commission, mentioned in the theme of the branch venue that in order to steadily promote the "323" tackling operation, gene technology is becoming more and more widely used in disease prevention and early screening. In 2021, the city completed the test test of 100,000 intestinal cancer in 27 days, and 4.3%of the subjects had abnormalities. Later, the colonoscopy diagnosis was performed. Through accurate screening, the patients won the early cashback and early intervention.

Event site.

The forum is based on the theme of "comprehensive health management in the new era to realize the health of the whole people", emphasizing the status and role of health management in the action of healthy China. At the genetic science and technology branch, Liu Qingxiang shared several representative applications of our city in the field of genetic testing with the theme of "gene technology helps the whole life cycle and empower health Wuhan".

"Screening and early diagnosis and early treatment are the key to reducing cancer mortality. The Wuhan Municipal Government uses cancer screening as a livelihood project, investing tens of millions of yuan per year, and included in the government's work goals for assessment." According to reports, starting from 2021, from 2021 The city launched the crowd of colorectal cancer screening project, completed the test testing of 100,000 sausage cancer in 27 days, and determined that 167 grass -roots health service agencies were used as sample collection agencies, 17 settlement hospitals were set as colonoscopy review institutions, and medical insurance was given during the treatment session. Policy tilt and subsidies to create an integrated closed -loop management model based on the Internet+community+hospitals.

In 2001, the city began the women's cervical cancer screening project. In 2016, the terminal intelligent micro -scanner+cytology artificial intelligence cloud diagnostic platform was launched. Screening for pain points such as experts, low quality, and difficult management. R & D results have won the National Invention Award, and have been certified by authoritative institutions such as CFDA, FDA, and European CE in China. The platform is widely used in 29 provinces and cities in China and Pakistan, Indonesia, Malaysia and other places. It has accumulated a wealth of more than a trillion -level mass data generated by tens of millions of cervical cell pathological samples and the rich experience in urban and rural screening. It has opened artificial intelligence cervix New era of cancer screening.

Event site.

In addition, the city has successively incorporated newborn deaf gene screening, baby congenital heart disease screening intervention, and free non -invasive genetic testing of pregnant women into the government's livelihood. Each stage and screening, diagnosis, and treatment. Actively carry out phenyloneuria, neate anemia and other common, death and severe disability or treatment of 156 scalability monocular disease carrier screening (ECS) in the early stages of pregnancy. Reduced 80%.

"The extensive application of genetic testing in the field of medicine is the successful practice of exploring the health management of the whole life cycle, and it is also a key trick to realize the high -quality development of health and health." Liu Qingxiang said that with the acceleration of aging, genetic technology will definitely welcome the welcoming The unprecedented strategic opportunities will help Wuhan's big health industry to go to a new level, and to empower the acceleration of high -quality development in Wuhan.

[Edit: Yu Lina]

For more exciting content, please download the "Da Wuhan" client in the major application markets.

- END -